Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Burden

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|December 7, 2007
FoxO3 controls autophagy in skeletal muscle in vivoCristina Mammucari, Giulia Milan, Vanina Romanello, et al.
Brain Communications|May 18, 2026
Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromesKelly Ho, Ofosu Adjei-Afriyie, Ricardo Carmona-Martinez, et al.
The Journal of Experimental Medicine|August 22, 2020
Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravisMiriam L Fichtner, Casey Vieni, Rachel L Redler, et al.
Molecular Ecology Resources|August 8, 2020
Primers to highly conserved elements optimized for qPCR-based telomere length measurement in vertebratesStephanie F Hudon, Esteban Palencia Hurtado, James D Beck, et al.
Cell|May 17, 1996
Agrin acts via a MuSK receptor complexDavid J Glass, David C Bowen, Trevor N Stitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4Maartje G Huijbers, Wei Zhang, Rinse Klooster, et al.
Cell|May 17, 1996
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivoThomas M DeChiara, David C Bowen, David M Valenzuela, et al.
Science Translational Medicine|September 18, 2024
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndromeRoeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
The New England Journal of Medicine|March 11, 2011
A dystroglycan mutation associated with limb-girdle muscular dystrophyYuji Hara, Burcu Balci-Hayta, Takako Yoshida-Moriguchi, et al.
Cancer Research|April 22, 2026
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 MedulloblastomaJake D Friske, Flore Cuisin, Paloma Guernalec, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|December 7, 2007
FoxO3 controls autophagy in skeletal muscle in vivoCristina Mammucari, Giulia Milan, Vanina Romanello, et al.
Brain Communications|May 18, 2026
Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromesKelly Ho, Ofosu Adjei-Afriyie, Ricardo Carmona-Martinez, et al.
The Journal of Experimental Medicine|August 22, 2020
Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravisMiriam L Fichtner, Casey Vieni, Rachel L Redler, et al.
Molecular Ecology Resources|August 8, 2020
Primers to highly conserved elements optimized for qPCR-based telomere length measurement in vertebratesStephanie F Hudon, Esteban Palencia Hurtado, James D Beck, et al.
Cell|May 17, 1996
Agrin acts via a MuSK receptor complexDavid J Glass, David C Bowen, Trevor N Stitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4Maartje G Huijbers, Wei Zhang, Rinse Klooster, et al.
Cell|May 17, 1996
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivoThomas M DeChiara, David C Bowen, David M Valenzuela, et al.
Science Translational Medicine|September 18, 2024
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndromeRoeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
The New England Journal of Medicine|March 11, 2011
A dystroglycan mutation associated with limb-girdle muscular dystrophyYuji Hara, Burcu Balci-Hayta, Takako Yoshida-Moriguchi, et al.
Cancer Research|April 22, 2026
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 MedulloblastomaJake D Friske, Flore Cuisin, Paloma Guernalec, et al.
Pageof 6